Biotech bosses silent as 11 jobs are lost
BOSSES AT Trinity Biotech have remained tight-lipped about the loss of 11 jobs at the company last week, despite having celebrated the introduction of a lucrative deal with a Japanese distributor the previous week.
It emerged last Friday that a number of jobs at the company had been shed, just days after media reports of a significant sale of their Destiny Max medical machine to the Asian market.
There are over 300 people employed at the Bray plant, which is the Irish headquarters of Trinity Biotech. Senior staff said last week that the Destiny Max sale meant that the sales and production volumes would see them becoming leaders in there market and sales and production volumes go up. Days later, 11 employees lost their jobs.
The company laid off almost 10 per cent of its work-force 15 months ago, in what management said was merely a ‘re-jig’.
Trinity Biotech has been under-fire from shareholders in recent months.
A representative of the company declined to comment on the latest round of job-losses.